In our study, increased proliferation and metastasis of CRC cells after UBTD1 overexpression could be reversed by a specific glycolysis inhibitor 2-DG in vitro and in vivo, which indicated that UBTD1 regulated CRC cell's malignant phenotype via promoting glycolysis. Here, UBTD1 is linked to colorectal carcinoma.